Suppr超能文献

米索前列醇对大鼠扑热息痛诱导的肝毒性的保护作用。

Misoprostol protection against acetaminophen-induced hepatotoxicity in the rat.

作者信息

Lim S P, Andrews F J, O'Brien P E

机构信息

Department of Surgery, Monash Medical School, Alfred Hospital, Prahran, Victoria, Australia.

出版信息

Dig Dis Sci. 1994 Jun;39(6):1249-56. doi: 10.1007/BF02093790.

Abstract

The hepatoprotective effects of misoprostol on acetaminophen (APAP)-induced toxicity were studied in the rat. Liver injury was evaluated at 36 hr after APAP administration by measuring serum ornithine carbamoyltransferase (OCT) and alanine aminotransferase (ALT) levels, by using tetranitroblue tetrazolium (TNBT) staining and by histological analysis. After APAP administration, peak serum levels of the drug were detected at 15 min. Liver GSH was depleted from control levels of 448 +/- 48 micrograms/g to 82 +/- 2 micrograms/g (P < 0.01) within 3 hr. Serum ALT levels increased significantly after 16 hr and H&E staining revealed significant hepatic necrosis after 12 hr. Rats treated with misoprostol before and after APAP administration showed reduced OCT and ALT levels at 36 hr of overdose (454 +/- 446 IU/liter and 2571 +/- 2944 IU/liter, respectively) compared to those without misoprostol treatment (1348 +/- 480 IU/liter and 6077 +/- 3025 IU/liter, respectively, P < 0.01). TNBT staining showed a reduced area of damage from 28.6 +/- 22.3% to 7.3 +/- 8.9% (P < 0.01), and H&E staining also showed less extensive hepatic necrosis in rats treated with misoprostol before and after the overdose. In a time sequence study, misoprostol treatment starting within 10 hr of overdose showed the same protective effect as when it was given before and after APAP ingestion. No protection was detected when the treatment was started during the development of hepatic injury. However, misoprostol given when injury was established seemed to be protective. Our results show that misoprostol protects the liver against APAP-induced injury if given within 10 hr of overdose.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在大鼠中研究了米索前列醇对乙酰氨基酚(APAP)诱导的毒性的肝保护作用。在给予APAP后36小时,通过测量血清鸟氨酸氨基甲酰转移酶(OCT)和丙氨酸氨基转移酶(ALT)水平、使用四硝基蓝四唑(TNBT)染色以及组织学分析来评估肝损伤。给予APAP后,在15分钟时检测到药物的血清峰值水平。肝谷胱甘肽(GSH)在3小时内从对照水平的448±48微克/克降至82±2微克/克(P<0.01)。血清ALT水平在16小时后显著升高,苏木精-伊红(H&E)染色显示12小时后出现明显的肝坏死。在给予APAP前后用米索前列醇治疗的大鼠,与未用米索前列醇治疗的大鼠相比,在过量用药36小时时OCT和ALT水平降低(分别为454±446国际单位/升和2571±2944国际单位/升)(未治疗组分别为1348±480国际单位/升和6077±3025国际单位/升,P<0.01)。TNBT染色显示损伤面积从28.6±22.3%降至7.3±8.9%(P<0.01),H&E染色也显示在过量用药前后用米索前列醇治疗的大鼠肝坏死范围较小。在一项时间序列研究中,在过量用药10小时内开始米索前列醇治疗显示出与在摄入APAP前后给予相同的保护作用。当在肝损伤发展过程中开始治疗时未检测到保护作用。然而,在损伤确立后给予米索前列醇似乎具有保护作用。我们的结果表明,如果在过量用药10小时内给予米索前列醇,其可保护肝脏免受APAP诱导的损伤。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验